Patil Neena M

EVP & Chief Legal OfficerJazz Pharmaceuticals plc (JAZZ) · full profile →Form 4 · filed Mar 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10.7M
Net Open-Market Flow
-$10.7M
Transactions
20
16 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 26, 2026Option exercise(M)875$113.10$99K58K
Feb 26, 2026Sell(S)875$192.07$168K57K
Feb 26, 2026Option exercise(M)27K$137.12$3.7M84K
Feb 26, 2026Sell(S)16K$190.28$3.0M68K
Feb 26, 2026Option exercise(M)3K$137.12$400K71K
Feb 26, 2026Sell(S)3K$189.81$553K68K
Feb 26, 2026Grant(A)10K$078K
Feb 26, 2026Sell(S)12K$191.65$2.2M67K
Feb 26, 2026Sell(S)4K$193.58$682K63K
Feb 26, 2026Sell(S)1K$190.00$202K62K
Feb 26, 2026Sell(S)549$190.80$105K62K
Feb 26, 2026Sell(S)2K$191.88$342K60K
Feb 26, 2026Sell(S)1K$192.79$195K59K
Feb 26, 2026Sell(S)197$193.60$38K59K
Feb 26, 2026Option exercise(M)20K$113.10$2.3M73K
Feb 26, 2026Sell(S)17K$192.53$3.2M57K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 26, 2026Option exercise(M)3K$00
Feb 26, 2026Option exercise(M)875$00
Feb 26, 2026Option exercise(M)20K$00
Feb 26, 2026Option exercise(M)27K$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001783908-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly: